{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:52:42Z","timestamp":1790833962629,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Division of Intramural Research, National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00192-018-3831-z","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T15:31:20Z","timestamp":1546961480000},"page":"1071-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Methodological approaches to botulinum toxin for the treatment of chronic pelvic pain, vaginismus, and vulvar pain disorders"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-0142","authenticated-orcid":false,"given":"Barbara Illowsky","family":"Karp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deionna","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"3831_CR1","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.36076\/ppj.2014\/17\/E141","volume":"17","author":"A Ahangari","year":"2014","unstructured":"Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17:E141\u20137.","journal-title":"Pain Physician"},{"key":"3831_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.eururo.2013.04.035","volume":"64","author":"DS Engeler","year":"2013","unstructured":"Engeler DS, Baranowski AP, Dinis-Oliveira P, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64:431\u20139.","journal-title":"Eur Urol"},{"key":"3831_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/pmt-2016-0052","volume":"7","author":"H Twiddy","year":"2017","unstructured":"Twiddy H, Bradshaw A, Chawla R, Johnson S, Lane N. Female chronic pelvic pain: the journey to diagnosis and beyond. Pain Manag. 2017;7:155\u20139.","journal-title":"Pain Manag"},{"key":"3831_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/AOG.0000000000000663","volume":"125","author":"P Stratton","year":"2015","unstructured":"Stratton P, Khachikyan I, Sinaii N, Ortiz R, Shah J. Association of chronic pelvic pain and endometriosis with signs of sensitization and myofascial pain. Obstet Gynecol. 2015;125:719\u201328.","journal-title":"Obstet Gynecol"},{"key":"3831_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/pm\/pny030","volume":"19","author":"A Levesque","year":"2018","unstructured":"Levesque A, Riant T, Ploteau S, Rigaud J, Labat JJ. Clinical criteria of central sensitization in chronic pelvic and perineal pain (convergences PP criteria): elaboration of a clinical evaluation tool based on formal expert consensus. Pain Med. 2018;19:2009\u201315.","journal-title":"Pain Med"},{"key":"3831_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1573397111666150619094524","volume":"11","author":"D Hoffman","year":"2015","unstructured":"Hoffman D. Central and peripheral pain generators in women with chronic pelvic pain: patient centered assessment and treatment. Curr Rheumatol Rev. 2015;11:146\u201366.","journal-title":"Curr Rheumatol Rev"},{"key":"3831_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/01443610400023106","volume":"26","author":"ED Reissing","year":"2005","unstructured":"Reissing ED, Brown C, Lord MJ, Binik YM, Khalife S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol. 2005;26:107\u201313.","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"3831_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmq050","volume":"17","author":"P Stratton","year":"2011","unstructured":"Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17:327\u201346.","journal-title":"Hum Reprod Update"},{"key":"3831_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1055\/s-0036-1597123","volume":"35","author":"JV Aredo","year":"2017","unstructured":"Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction. Semin Reprod Med. 2017;35:88\u201397.","journal-title":"Semin Reprod Med"},{"key":"3831_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/AJP.0b013e31821c98ec","volume":"27","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Zolnoun DA, Francisco EM, Holden JK, Dennis RG, Tommerdahl M. Altered central sensitization in subgroups of women with vulvodynia. Clin J Pain. 2011;27:755\u201363.","journal-title":"Clin J Pain"},{"key":"3831_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/IJWH.S37660","volume":"6","author":"LA Sadownik","year":"2014","unstructured":"Sadownik LA. Etiology, diagnosis, and clinical management of vulvodynia. Int J Womens Health. 2014;6:437\u201349.","journal-title":"Int J Womens Health"},{"key":"3831_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jbmt.2008.06.006","volume":"12","author":"JP Shah","year":"2008","unstructured":"Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008;12:371\u201384.","journal-title":"J Bodyw Mov Ther"},{"issue":"Suppl 1","key":"3831_CR13","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","volume":"17","author":"KR Aoki","year":"2011","unstructured":"Aoki KR, Francis J. Updates on the antinociceptive mechanism hypothesis of botulinum toxin a. Parkinsonism Relat Disord. 2011;17(Suppl 1):S28\u201333.","journal-title":"Parkinsonism Relat Disord"},{"key":"3831_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/toxins10060224","volume":"10","author":"J Park","year":"2018","unstructured":"Park J, Chung ME. Botulinum toxin for central neuropathic pain. Toxins (Basel). 2018;10:224. https:\/\/doi.org\/10.3390\/toxins10060224 .","journal-title":"Toxins (Basel)"},{"key":"3831_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1756285616677005","volume":"10","author":"CM Escher","year":"2017","unstructured":"Escher CM, Paracka L, Dressler D, Kollewe K. Botulinum toxin in the management of chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord. 2017;10:127\u201335.","journal-title":"Ther Adv Neurol Disord"},{"key":"3831_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-017-0744-z","volume":"18","author":"G Sandrini","year":"2017","unstructured":"Sandrini G, De Icco R, Tassorelli C, Smania N, Tamburin S. Botulinum neurotoxin type a for the treatment of pain: not just in migraine and trigeminal neuralgia. J Headache Pain. 2017;18:38.","journal-title":"J Headache Pain"},{"key":"3831_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","volume":"147","author":"Y Safarpour","year":"2018","unstructured":"Safarpour Y, Jabbari B. Botulinum toxin treatment of pain syndromes -an evidence based review. Toxicon. 2018;147:120\u20138.","journal-title":"Toxicon"},{"key":"3831_CR18","doi-asserted-by":"crossref","unstructured":"Matak I, Lackovic Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 2014;119-120:39\u201359.","DOI":"10.1016\/j.pneurobio.2014.06.001"},{"key":"3831_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0140-6736(05)64862-3","volume":"349","author":"MF Brin","year":"1997","unstructured":"Brin MF, Vapnek JM. Treatment of vaginismus with botulinum toxin injections. Lancet. 1997;349:252\u20133.","journal-title":"Lancet"},{"key":"3831_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","volume":"44","author":"SK Jarvis","year":"2004","unstructured":"Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type a in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol. 2004;44:46\u201350.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"3831_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1471-0528.2004.00315.x","volume":"112","author":"AJ Thomson","year":"2005","unstructured":"Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG. The use of botulinum toxin type a (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG. 2005;112:247\u20139.","journal-title":"BJOG"},{"key":"3831_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","volume":"108","author":"JA Abbott","year":"2006","unstructured":"Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108:915\u201323.","journal-title":"Obstet Gynecol"},{"key":"3831_CR23","unstructured":"Stratton P, Tandon H, Sinaii N, Shah J, Karp BI. Botulinum toxin for chronic pelvic pain in endometriosis. World Congress on Endometriosis. Vancouver, B.C. 2017."},{"key":"3831_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.toxicon.2012.11.018","volume":"63","author":"EM Nesbitt-Hawes","year":"2013","unstructured":"Nesbitt-Hawes EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A\u2014single vs. repeat injections. Toxicon. 2013;63:83\u20137.","journal-title":"Toxicon"},{"key":"3831_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/uog.17537","volume":"51","author":"EM Nesbitt-Hawes","year":"2018","unstructured":"Nesbitt-Hawes EM, Dietz HP, Abbott JA. Four-dimensional ultrasound guidance for pelvic floor Botulinum toxin-A injection in chronic pelvic pain: a novel technique. Ultrasound Obstet Gynecol. 2018;51:396\u2013400.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3831_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/SPV.0b013e3182989fd8","volume":"19","author":"A Adelowo","year":"2013","unstructured":"Adelowo A, Hacker MR, Shapiro A, Modest AM, Elkadry E. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Female Pelvic Med Reconstr Surg. 2013;19:288\u201392.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR27","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.toxicon.2014.11.021","volume":"93","author":"E Bautrant","year":"2015","unstructured":"Bautrant E, Quintas-Marqu\u00e8s L, Eggermont J, et al. Use of botulinum neurotoxin type A (Xeomin) injections to the perineal muscles in cases of perineal pain and dysfunction associated with pelvic floor muscle overcontraction and myalgia. Toxicon. 2015;93:S7\u20138.","journal-title":"Toxicon"},{"key":"3831_CR28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181bb0dbb","volume":"114","author":"L Bertolasi","year":"2009","unstructured":"Bertolasi L, Frasson E, Cappelletti JY, Vicentini S, Bordignon M, Graziottin A. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol. 2009;114:1008\u201316.","journal-title":"Obstet Gynecol"},{"key":"3831_CR29","first-page":"1025","volume":"33","author":"A Bhide","year":"2014","unstructured":"Bhide A, Bray R, Gopalan V, Fernando R, Khullar V, Digesu A. To assess whether botulinum type A toxin injection to the pelvic floor improves symptoms and quality of life in women with chronic pelvic pain (CPP) due to pelvic floor muscle hyperalgesia. Neurourol Urodyn. 2014;33:1025.","journal-title":"Neurourol Urodyn"},{"key":"3831_CR30","first-page":"635","volume":"51","author":"CS Brown","year":"2006","unstructured":"Brown CS, Glazer HI, Vogt V, Menkes D, Bachmann G. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med. 2006;51:635\u201341.","journal-title":"J Reprod Med"},{"key":"3831_CR31","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.ajog.2011.12.023","volume":"206","author":"TJ Brueseke","year":"2012","unstructured":"Brueseke TJ, Lane FL. Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin. Am J Obstet Gynecol. 2012;206:e7\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"3831_CR32","first-page":"467","volume":"51","author":"DD Dykstra","year":"2006","unstructured":"Dykstra DD, Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study. J Reprod Med. 2006;51:467\u201370.","journal-title":"J Reprod Med"},{"key":"3831_CR33","first-page":"117","volume":"32","author":"D El-Khawand","year":"2013","unstructured":"El-Khawand D, Wehbe S, O'Hare P, et al. Botulinum toxin a injections into pelvic floor muscles under electromyographic guidance for women with refractory high tone pelvic floor dysfunction: three-month follow-up data of an ongoing pilot study. Neurourol Urodyn. 2013;32:117.","journal-title":"Neurourol Urodyn"},{"key":"3831_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/SPV.0000000000000177","volume":"21","author":"D Morrissey","year":"2015","unstructured":"Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O'Hare P III, Whitmore K. Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study. Female Pelvic Med Reconstr Surg. 2015;21:277\u201382.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/ajo.12381","volume":"55","author":"SF Evans","year":"2015","unstructured":"Evans SF, Porter JM. Simplified technique for injection of botulinum toxin to obturator internus muscle using ultrasound-guided nerve stimulation for persistent pelvic pain. Aust N Z J Obstet Gynaecol. 2015;55:612\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"3831_CR36","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/j.1743-6109.2011.02247.x","volume":"8","author":"WM Fageeh","year":"2011","unstructured":"Fageeh WM. Different treatment modalities for refractory vaginismus in western Saudi Arabia. J Sex Med. 2011;8:1735\u20139.","journal-title":"J Sex Med"},{"key":"3831_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jpain.2005.01.353","volume":"6","author":"NM Gajraj","year":"2005","unstructured":"Gajraj NM. Botulinum toxin A injection of the obturator internus muscle for chronic perineal pain. J Pain. 2005;6:333\u20137.","journal-title":"J Pain"},{"key":"3831_CR38","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/01.AOG.0000141441.41178.6b","volume":"104","author":"S Ghazizadeh","year":"2004","unstructured":"Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol. 2004;104:922\u20135.","journal-title":"Obstet Gynecol"},{"key":"3831_CR39","first-page":"1033","volume":"3","author":"S Ghazizadeh","year":"2016","unstructured":"Ghazizadeh S, Abedi J, Pourmatroud AJ, Raiisi F, Lesanpezeshki M. Comparison of 500 units vs 250 units of botulinum toxin (abobotulinumtoxinA) for the treatment of severe vaginismus. J Bacteriol Mycol. 2016;3:1033\u20136.","journal-title":"J Bacteriol Mycol"},{"key":"3831_CR40","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1743-6109.2011.02270.x","volume":"8","author":"AT Goldstein","year":"2011","unstructured":"Goldstein AT, Burrows LJ, Kellogg-Spadt S. Intralevator injection of botulinum toxin for the treatment of hypertonic pelvic floor muscle dysfunction and vestibulodynia. J Sex Med. 2011;8:1287\u201390.","journal-title":"J Sex Med"},{"key":"3831_CR41","first-page":"S93","volume":"17","author":"BA Greenleaf","year":"2011","unstructured":"Greenleaf BA, McKinney TB, Greenleaf BA, et al. Vaginismus and botulinum toxin a: A measurement of treatment. Female Pelvic Med Reconstr Surg. 2011;17:S93.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR42","first-page":"S143","volume":"21","author":"GE Halder","year":"2015","unstructured":"Halder GE, Scott L, Wyman AM, Mora N, Bassaly R, Hoyte L. Botox with physical therapy for myofascial pelvic pain. Female Pelvic Med Reconstr Surg. 2015;21:S143.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4111\/icu.2017.58.2.134","volume":"58","author":"GE Halder","year":"2017","unstructured":"Halder GE, Scott L, Wyman A, et al. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain. Investig Clin Urol. 2017;58:134\u20139.","journal-title":"Investig Clin Urol"},{"key":"3831_CR44","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.jvir.2015.12.667","volume":"27","author":"A Kieger","year":"2016","unstructured":"Kieger A, Marker D, Hong K. CT-guided intramuscular Botox injection and the evolving chronic pelvic pain practice paradigm. J Vasc Interv Radiol. 2016;27:S262.","journal-title":"J Vasc Interv Radiol"},{"key":"3831_CR45","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1097\/AAP.0000000000000330","volume":"41","author":"P Zavridis","year":"2016","unstructured":"Zavridis P, Moreland A, Minwell G, Kieger A, Yim D, Hong K. Safety and early results of CT-guided intramuscular injection of botulinum toxin-A for the management of myofascial pelvic pain. Reg Anesth Pain Med. 2016;41:e118.","journal-title":"Reg Anesth Pain Med"},{"key":"3831_CR46","unstructured":"Moreland A, Minwell G, Kieger A, Yim D, Hong K. CT-guided intramuscular injection of botulinum toxin A for treatment of myofascial pelvic pain: single center evaluation of safety and early efficacy (abstract). Radiol Soc N Amer 2016 Scientific Assembly and Annual Meeting, November 27\u2013December 2, 2016, Chicago IL. 2016. archive.rsna.org\/2016\/16003493.html . Accessed 27 February 2017."},{"key":"3831_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11934-013-0360-7","volume":"14","author":"RM Moldwin","year":"2013","unstructured":"Moldwin RM, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14:409\u201317.","journal-title":"Curr Urol Rep"},{"key":"3831_CR48","first-page":"S114","volume":"19","author":"B Orasanu","year":"2013","unstructured":"Orasanu B, Guetzko ME, Mahajan S. Myobloc\u00ae for the treatment of myofascial pelvic pain secondary resistant to Botox\u00ae. Female Pelvic Med Reconstr Surg. 2013;19:S114.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR49","doi-asserted-by":"publisher","first-page":"455e","DOI":"10.1097\/PRS.0b013e3181bf7f11","volume":"124","author":"PT Pacik","year":"2009","unstructured":"Pacik PT. Botox treatment for vaginismus. Plast Reconstr Surg. 2009;124:455e\u20136e.","journal-title":"Plast Reconstr Surg"},{"key":"3831_CR50","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.esxm.2017.02.002","volume":"5","author":"PT Pacik","year":"2017","unstructured":"Pacik PT, Geletta S. Vaginismus treatment: clinical trials follow up 241 patients. Sex Med. 2017;5:e114\u201323.","journal-title":"Sex Med"},{"key":"3831_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jabr.12037","volume":"20","author":"PT Pacik","year":"2015","unstructured":"Pacik PT, Geletta S. OnabotulinumtoxinA as part of a multimodal program to treat vaginismus. J Appl Biobehav Res. 2015;20:25\u201336.","journal-title":"J Appl Biobehav Res"},{"key":"3831_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/AOG.0b013e3181998ce1","volume":"114","author":"AJ Park","year":"2009","unstructured":"Park AJ, Paraiso MF. Successful use of botulinum toxin type A in the treatment of refractory postoperative dyspareunia. Obstet Gynecol. 2009;114:484\u20137.","journal-title":"Obstet Gynecol"},{"key":"3831_CR53","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1097\/SPV.0b013e31827de9f8","volume":"19","author":"RJ Pope","year":"2013","unstructured":"Pope RJ, Mahajan S. Onabotulinum toxin A for myalgia of multiple sites including the vagina. Female Pelvic Med Reconstr Surg. 2013;19:S179.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3831_CR54","first-page":"S164","volume":"16","author":"W Quirino","year":"2010","unstructured":"Quirino W, James RL, Mahajan ST. Pelvic floor botulinum a toxin injection for the treatment of myofascial pelvic pain. J Pelvic Med Surg. 2010;16:S164.","journal-title":"J Pelvic Med Surg"},{"key":"3831_CR55","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000079620","volume":"58","author":"S Romito","year":"2004","unstructured":"Romito S, Bottanelli M, Pellegrini M, Vicentini S, Rizzuto N, Bertolasi L. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Investig. 2004;58:164\u20137.","journal-title":"Gynecol Obstet Investig"},{"key":"3831_CR56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/sj.ijir.3901487","volume":"19","author":"H Yoon","year":"2007","unstructured":"Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res. 2007;19:84\u20137.","journal-title":"Int J Impot Res"},{"key":"3831_CR57","first-page":"177","volume":"10","author":"P Pacik","year":"2013","unstructured":"Pacik P. Vaginismus: treatment using the botulinum toxin A program. J Sexual Med. 2013;10:177.","journal-title":"J Sexual Med"},{"key":"3831_CR58","first-page":"64","volume":"8","author":"P Pacik","year":"2011","unstructured":"Pacik P. Vaginismus: treatment with intravaginal Botox and dilation under anesthesia. A prospective study of 70 consecutive patients. J Sex Med. 2011;8:64.","journal-title":"J Sex Med"},{"key":"3831_CR59","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00192-012-2015-5","volume":"24","author":"AA Bhide","year":"2013","unstructured":"Bhide AA, Puccini F, Khullar V, Elneil S, Digesu GA. Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. Int Urogynecol J. 2013;24:1429\u201334.","journal-title":"Int Urogynecol J"},{"key":"3831_CR60","first-page":"169","volume":"50","author":"M Li","year":"2005","unstructured":"Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci. 2005;50:169\u201372.","journal-title":"J Forensic Sci"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3831-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-018-3831-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3831-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T21:42:40Z","timestamp":1662759760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-018-3831-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3831"],"URL":"https:\/\/doi.org\/10.1007\/s00192-018-3831-z","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest related to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Dr Karp, Dr Stratton are investigators and Ms Tandon was a research assistant on a different study for which the National Institutes of Health received a grant from Allergan, Inc, the manufacturer of onabotulinumtoxinA (Botox). Dr Karp is also an associate investigator on one study for which the Icahn School of Medicine at Mt Sinai received a grant from Allergan, Inc, and another study for which the National Institutes of Health received a grant from Merz, Inc, the manufacturer of incobotulinumtoxinA (Xeomin). Ms Vigil has no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}